Revium Rx RVRC
OTC RVRC
$1.43 +0.00 (+0.00%)
At close: Nov 9, 2026 · 4:00 PM EST

Revium Rx (RVRC) Capital Expenditures (2026)

Updated

Revium Rx's Capital Expenditures was $7,000 in FY2025, up 133.3% from $3,000 in FY2024.

Analysis

Revium Rx (RVRC) Capital Expenditures (2026) Analysis & Trends

  • Per Business Quant data, Capital Expenditures in earlier years was $3,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 3.18 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 1.36 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 301.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.04 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -3.30 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 587.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 237.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 573.00 Mn
10 Revium Rx 86.84 Mn 75.21 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1,000.00
API Access

Revium Rx Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=RVRC&period=max&api_key=YOUR_API_KEY